{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:14:57Z","timestamp":1792653297531,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neulet.2025.138412","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:14:40Z","timestamp":1760109280000},"page":"138412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The role of BDNF\/PI3K\/AKT\/Nrf2 signaling in nicotine\u2019s protective effects against MPTP-induced Parkinson\u2019s disease"],"prefix":"10.1016","volume":"868","author":[{"given":"Nikoloz","family":"Zhgenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterine","family":"Bakuradze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otar","family":"Bibilashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7324-1495","authenticated-orcid":false,"given":"Nana","family":"Koshoridze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.neulet.2025.138412_b0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2025.138412_b0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.neulet.2025.138412_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cnp.2022.06.002","article-title":"Clinical neurophysiology of Parkinson's disease and parkinsonism","volume":"7","author":"Chen","year":"2022","journal-title":"Clin. Neurophysiol. Pract."},{"issue":"Suppl 1","key":"10.1016\/j.neulet.2025.138412_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.neulet.2025.138412_b0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JPD-181306","article-title":"Progression of cognitive decline in Parkinson\u2019s disease","volume":"8","author":"Roheger","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neulet.2025.138412_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegeneration"},{"key":"10.1016\/j.neulet.2025.138412_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.580634","article-title":"The convergence of alpha-synuclein, mitochondrial, and lysosomal pathways in vulnerability of midbrain dopaminergic neurons in Parkinson's disease","volume":"8","author":"Minakaki","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.neulet.2025.138412_b0040","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.3390\/ijms20215312","article-title":"The overcrowded crossroads: mitochondria, alpha-synuclein, and the endo-lysosomal system interaction in Parkinson's disease","volume":"20","author":"Lin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3\u20134","key":"10.1016\/j.neulet.2025.138412_b0045","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0891-5849(99)00075-1","article-title":"Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA","volume":"27","author":"Martignoni","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.neulet.2025.138412_b0050","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/antiox12040955","article-title":"Oxidative stress and neuroinflammation in Parkinson's disease: the role of dopamine oxidation products","volume":"12","author":"Chakrabarti","year":"2023","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.neulet.2025.138412_b0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3233\/JPD-230372","article-title":"Effectiveness of continuous dopaminergic therapies in Parkinson's disease: a review of L-DOPA pharmacokinetics\/pharmacodynamics","volume":"14","author":"Demailly","year":"2024","journal-title":"J. Parkinsons Dis."},{"issue":"20","key":"10.1016\/j.neulet.2025.138412_b0060","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","article-title":"Tobacco smoking and the risk of Parkinson disease: a 65-year follow-up of 30,000 male British doctors","volume":"94","author":"Mappin-Kasirer","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2025.138412_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107022","article-title":"Smoking exposure and Parkinson's disease: a UK Brain Bank pathology-validated case-control study","volume":"125","author":"di Biase","year":"2024","journal-title":"Parkinsonism, Related Disorders"},{"issue":"8","key":"10.1016\/j.neulet.2025.138412_b0070","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/biomedicines13081814","article-title":"Nicotine Therapy for Parkinson\u2019s disease: a meta-analysis of randomized controlled trials","volume":"13","author":"Liang","year":"2025","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.neulet.2025.138412_b0075","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.21900","article-title":"Nicotine and Parkinson's disease: implications for therapy","volume":"23","author":"Quik","year":"2008","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12640-018-9931-1","article-title":"Nicotine-induced neuroprotection in rotenone in vivo and in vitro models of Parkinson's disease: evidences for the involvement of the labile iron pool level as the underlying mechanism","volume":"35","author":"Mouhape","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neulet.2025.138412_b0085","doi-asserted-by":"crossref","first-page":"e3933","DOI":"10.7717\/peerj.3933","article-title":"The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage","volume":"5","author":"Lu","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.neulet.2025.138412_b0090","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1038\/s41598-021-88910-4","article-title":"Nicotine suppresses Parkinson\u2019s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels","volume":"11","author":"Carvajal-Oliveros","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2025.138412_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1239009","article-title":"Nicotine-mediated effects in neuronal and mouse models of synucleinopathy","volume":"17","author":"Fares","year":"2023","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2025.138412_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12640-012-9326-7","article-title":"Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease","volume":"22","author":"Mu\u00f1oz","year":"2012","journal-title":"Neurotox. Res."},{"issue":"10","key":"10.1016\/j.neulet.2025.138412_b0105","first-page":"1417","article-title":"Effect of nicotine on the energy metabolism of substantia nigra cells in mptp-induced Parkinson\u2019s disease","volume":"28","author":"Zhgenti","year":"2025","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.neulet.2025.138412_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104846","article-title":"The PI3K-AKT pathway: a plausible therapeutic target in Parkinson's disease","volume":"129","author":"Goyal","year":"2023","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.neulet.2025.138412_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156966","article-title":"Activation of BDNF-TrkB-PI3K-AKT signaling pathway by Tong-Qiao-Huo-Xue Decoction facilitates nerve regeneration and mitigates cerebral ischemia-reperfusion injury","volume":"145","author":"Peng","year":"2025","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharmacol."},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0120","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12974-017-0930-6","article-title":"Brain-derived neurotrophic factor reduces inflammation and hippocampal apoptosis in experimental Streptococcus pneumoniae meningitis","volume":"14","author":"Xu","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"11","key":"10.1016\/j.neulet.2025.138412_b0125","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.7150\/ijbs.97263","article-title":"The PI3K\/Akt-Nrf2 signaling pathway and mitophagy synergistically mediate hydroxytyrosol to alleviate intestinal oxidative damage","volume":"20","author":"Wen","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neulet.2025.138412_b0130","article-title":"Protective effect of sargahydroquinoic acid against A\u03b225-35-evoked damage via PI3K\/Akt mediated Nrf2 antioxidant defense system","volume":"144","author":"Yoon","year":"2021","journal-title":"Biomed. Pharmacother.= Biomed. Pharmacother."},{"key":"10.1016\/j.neulet.2025.138412_b0135","series-title":"Guide for the Care and use of Laboratory Animals","author":"\u201cFront Matter.\u201d National Research Council","year":"2011"},{"issue":"3","key":"10.1016\/j.neulet.2025.138412_b0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00213-006-0441-0","article-title":"Guidelines on nicotine dose selection for in vivo research","volume":"190","author":"Matta","year":"2007","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neulet.2025.138412_b0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","article-title":"Nicotine chemistry, metabolism, kinetics and biomarkers","volume":"192","author":"Benowitz","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neulet.2025.138412_b0155","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"issue":"3","key":"10.1016\/j.neulet.2025.138412_b0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000345959","article-title":"Morphological and morphometric analysis of the hippocampus in Wistar rats with experimental hydrocephalus","volume":"48","author":"Taveira","year":"2012","journal-title":"Pediatr. Neurosurg."},{"issue":"1\u20132","key":"10.1016\/j.neulet.2025.138412_b0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.eplepsyres.2011.02.008","article-title":"Alterations of GABA(A) and glutamate receptor subunits and heat shock protein in rat hippocampus following traumatic brain injury and in posttraumatic epilepsy","volume":"95","author":"Kharlamov","year":"2011","journal-title":"Epilepsy Res."},{"issue":"Pt 2","key":"10.1016\/j.neulet.2025.138412_b0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1113\/jphysiol.2005.098012","article-title":"Ca2+\/calmodulin protein kinase II and memory: learning-related changes in a localized region of the domestic chick brain","volume":"569","author":"Solomonia","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neulet.2025.138412_b0175","first-page":"115","article-title":"Acute hippocampal slice preparation and hippocampal slice cultures. Methods in molecular biology (Clifton","volume":"758","author":"Lein","year":"2011","journal-title":"N.J.)"},{"issue":"7","key":"10.1016\/j.neulet.2025.138412_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.736","article-title":"Hippocampal slice preparation in rats acutely suppresses immunoreactivity of microtubule-associated protein (Map2) and glycogen levels without affecting numbers of glia or levels of the glutamate transporter VGlut1","volume":"7","author":"Stein","year":"2017","journal-title":"Brain and Behavior"},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/09291016.2017.1333198","article-title":"Creatine\u2013facilitated protection of stress caused by disrupted circadian rhythm","volume":"49","author":"Burjanadze","year":"2017","journal-title":"Biol. Rhythm Res."},{"key":"10.1016\/j.neulet.2025.138412_b0190","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-025-03409-1","article-title":"Unrevealing the molecular mechanisms of MPTP-induced Parkinson\u2019s in experimental animals","author":"Mondal","year":"2025","journal-title":"Med. Chem. Res."},{"issue":"11","key":"10.1016\/j.neulet.2025.138412_b0195","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/biomedicines10112929","article-title":"Neuroprotective effects of nicotinamide against MPTP-induced Parkinson\u2019s disease in mice: impact on oxidative stress, neuroinflammation, Nrf2\/HO-1 and TLR4 signaling pathways","volume":"10","author":"Rehman","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neulet.2025.138412_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.581191","article-title":"Chemically induced models of Parkinson's disease: history and perspectives for the involvement of ferroptosis","volume":"14","author":"Wen","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.neulet.2025.138412_b0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.13189\/ijbb.2023.110301","article-title":"Exploring the neuroprotective effects of nicotine against mptp-induced neuronal damage in mice: insights into antioxidant system","volume":"11","author":"Zhgenti","year":"2023","journal-title":"IJBB"},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mdc3.13344","article-title":"MPTP parkinsonism and implications for understanding Parkinson's Disease","volume":"9","author":"AlShimemeri","year":"2021","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/j.neulet.2025.138412_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1088957","article-title":"Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease","volume":"14","author":"Ruan","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neulet.2025.138412_b0220","doi-asserted-by":"crossref","unstructured":"S. Nara, Y. Yamaguti, I. Tsuda, Review: Nicotinic acetylcholine receptors to regulate important brain activity-what occurs at the molecular level?. Cognitive neurodynamics, 18(3) (2023) 1\u20136. Advance online publication. https:\/\/doi.org\/10.1007\/s11571-023-09975-7.","DOI":"10.1007\/s11571-023-09975-7"},{"issue":"12","key":"10.1016\/j.neulet.2025.138412_b0225","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/jnr.25239","article-title":"Apoptosis in the neuroprotective effect of \u03b17 nicotinic receptor in neurodegenerative models","volume":"101","author":"Mugayar","year":"2023","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0230","first-page":"294","article-title":"Brain-derived neurotrophic factor inhibits hyperglycemia-induced apoptosis and downregulation of synaptic plasticity-related proteins in hippocampal neurons via the PI3K\/Akt pathway","volume":"43","author":"Zhong","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.neulet.2025.138412_b0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: from synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neulet.2025.138412_b0240","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","article-title":"The cholinergic system and Parkinson disease","volume":"221","author":"Bohnen","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"13","key":"10.1016\/j.neulet.2025.138412_b0245","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2025.138412_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1437939","article-title":"Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications","volume":"15","author":"Mayer","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025003015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025003015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:17:23Z","timestamp":1763619443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394025003015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0304394025003015"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138412","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of BDNF\/PI3K\/AKT\/Nrf2 signaling in nicotine\u2019s protective effects against MPTP-induced Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"138412"}}